Publication | Closed Access
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.
313
Citations
8
References
1992
Year
Taxol can be delivered by the IP route with both an acceptable toxicity profile and a major pharmacokinetic advantage for cavity exposure.
| Year | Citations | |
|---|---|---|
Page 1
Page 1